These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 34367174)

  • 41. The natural killer cell dysfunction of aged mice is due to the bone marrow stroma and is not restored by IL-15/IL-15Rα treatment.
    Nair S; Fang M; Sigal LJ
    Aging Cell; 2015 Apr; 14(2):180-90. PubMed ID: 25399821
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Interleukin 15-mediated induction of cytotoxic effector cells capable of eliminating Epstein-Barr virus-transformed/immortalized lymphocytes in culture.
    Sharif-Askari E; Fawaz LM; Tran P; Ahmad A; Menezes J
    J Natl Cancer Inst; 2001 Nov; 93(22):1724-32. PubMed ID: 11717333
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Transcription factor KLF2 regulates homeostatic NK cell proliferation and survival.
    Rabacal W; Pabbisetty SK; Hoek KL; Cendron D; Guo Y; Maseda D; Sebzda E
    Proc Natl Acad Sci U S A; 2016 May; 113(19):5370-5. PubMed ID: 27114551
    [TBL] [Abstract][Full Text] [Related]  

  • 44. IL-12/IL-18-preactivated donor NK cells enhance GVL effects and mitigate GvHD after allogeneic hematopoietic stem cell transplantation.
    Song Y; Hu B; Liu Y; Jin Z; Zhang Y; Lin D; Zhu Y; Lei L; Gong H; Mei Y; Teo HY; Wu D; Liu H
    Eur J Immunol; 2018 Apr; 48(4):670-682. PubMed ID: 29282719
    [TBL] [Abstract][Full Text] [Related]  

  • 45. IL-15 promotes regulatory T cell function and protects against diabetes development in NK-depleted NOD mice.
    Xia J; Liu W; Hu B; Tian Z; Yang Y
    Clin Immunol; 2010 Feb; 134(2):130-9. PubMed ID: 19875339
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Role of interleukin-2 (IL-2), IL-7, and IL-15 in natural killer cell differentiation from cord blood hematopoietic progenitor cells and from gamma c transduced severe combined immunodeficiency X1 bone marrow cells.
    Cavazzana-Calvo M; Hacein-Bey S; de Saint Basile G; De Coene C; Selz F; Le Deist F; Fischer A
    Blood; 1996 Nov; 88(10):3901-9. PubMed ID: 8916956
    [TBL] [Abstract][Full Text] [Related]  

  • 47. A-Disintegrin and Metalloproteinase (ADAM) 17 Enzymatically Degrades Interferon-gamma.
    Kanzaki H; Shinohara F; Suzuki M; Wada S; Miyamoto Y; Yamaguchi Y; Katsumata Y; Makihira S; Kawai T; Taubman MA; Nakamura Y
    Sci Rep; 2016 Aug; 6():32259. PubMed ID: 27573075
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The proinflammatory cytokines IL-2, IL-15 and IL-21 modulate the repertoire of mature human natural killer cell receptors.
    de Rham C; Ferrari-Lacraz S; Jendly S; Schneiter G; Dayer JM; Villard J
    Arthritis Res Ther; 2007; 9(6):R125. PubMed ID: 18053164
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The engagement of CTLA-4 on primary melanoma cell lines induces antibody-dependent cellular cytotoxicity and TNF-α production.
    Laurent S; Queirolo P; Boero S; Salvi S; Piccioli P; Boccardo S; Minghelli S; Morabito A; Fontana V; Pietra G; Carrega P; Ferrari N; Tosetti F; Chang LJ; Mingari MC; Ferlazzo G; Poggi A; Pistillo MP
    J Transl Med; 2013 May; 11():108. PubMed ID: 23634660
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Preferential proliferation of natural killer cells among peripheral blood mononuclear cells cocultured with B lymphoblastoid cell lines.
    Perussia B; Ramoni C; Anegon I; Cuturi MC; Faust J; Trinchieri G
    Nat Immun Cell Growth Regul; 1987; 6(4):171-88. PubMed ID: 2960890
    [TBL] [Abstract][Full Text] [Related]  

  • 51. In-vitro activation of natural killer cells from regional lymph nodes of melanoma patients with interleukin-2 and interleukin-15.
    Vuletić AM; Jovanić IP; Jurišić VB; Milovanović ZM; Nikolić SS; Tanić NT; Konjević GM
    Melanoma Res; 2015 Feb; 25(1):22-34. PubMed ID: 25380182
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Interleukin (IL)-15 in combination with IL-2, fms-like tyrosine kinase-3 ligand and anti-CD3 significantly enhances umbilical cord blood natural killer (NK) cell and NK-cell subset expansion and NK function.
    Satwani P; van de Ven C; Ayello J; Cairo D; Simpson LL; Baxi L; Cairo MS
    Cytotherapy; 2011 Jul; 13(6):730-8. PubMed ID: 21413839
    [TBL] [Abstract][Full Text] [Related]  

  • 53. NK cell adoptive transfer combined with Ontak-mediated regulatory T cell elimination induces effective adaptive antitumor immune responses.
    Salagianni M; Lekka E; Moustaki A; Iliopoulou EG; Baxevanis CN; Papamichail M; Perez SA
    J Immunol; 2011 Mar; 186(6):3327-35. PubMed ID: 21317394
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Cytokine requirements for the growth and development of mouse NK cells in vitro.
    Toomey JA; Gays F; Foster D; Brooks CG
    J Leukoc Biol; 2003 Aug; 74(2):233-42. PubMed ID: 12885940
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Rapid generation of potent and tumor-specific cytotoxic T lymphocytes by interleukin 18 using dendritic cells and natural killer cells.
    Tanaka F; Hashimoto W; Okamura H; Robbins PD; Lotze MT; Tahara H
    Cancer Res; 2000 Sep; 60(17):4838-44. PubMed ID: 10987295
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Two-compartment model of NK cell proliferation: insights from population response to IL-15 stimulation.
    Zhao YM; French AR
    J Immunol; 2012 Apr; 188(7):2981-90. PubMed ID: 22379026
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Regulatory role of membrane-bound form interleukin-15 on human uterine microvascular endothelial cells in circulating CD16(-) natural killer cell extravasation into human endometrium.
    Kitaya K; Yasuo T
    Biol Reprod; 2013 Sep; 89(3):70. PubMed ID: 23904514
    [TBL] [Abstract][Full Text] [Related]  

  • 58. ADAM17 selectively activates the IL-6 trans-signaling/ERK MAPK axis in KRAS-addicted lung cancer.
    Saad MI; Alhayyani S; McLeod L; Yu L; Alanazi M; Deswaerte V; Tang K; Jarde T; Smith JA; Prodanovic Z; Tate MD; Balic JJ; Watkins DN; Cain JE; Bozinovski S; Algar E; Kohmoto T; Ebi H; Ferlin W; Garbers C; Ruwanpura S; Sagi I; Rose-John S; Jenkins BJ
    EMBO Mol Med; 2019 Apr; 11(4):. PubMed ID: 30833304
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Selective expansion and partial activation of human NK cells and NK receptor-positive T cells by IL-2 and IL-15.
    Dunne J; Lynch S; O'Farrelly C; Todryk S; Hegarty JE; Feighery C; Doherty DG
    J Immunol; 2001 Sep; 167(6):3129-38. PubMed ID: 11544298
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Transpresentation of interleukin-15 by IL-15/IL-15Rα mRNA-engineered human dendritic cells boosts antitumoral natural killer cell activity.
    Van den Bergh J; Willemen Y; Lion E; Van Acker H; De Reu H; Anguille S; Goossens H; Berneman Z; Van Tendeloo V; Smits E
    Oncotarget; 2015 Dec; 6(42):44123-33. PubMed ID: 26675759
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.